» Articles » PMID: 16641105

Phosphorylation of TNF-alpha Converting Enzyme by Gastrin-releasing Peptide Induces Amphiregulin Release and EGF Receptor Activation

Overview
Specialty Science
Date 2006 Apr 28
PMID 16641105
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors induce EGF receptor (EGFR) signaling, leading to the proliferation and invasion of cancer cells. Elucidation of the mechanism of EGFR activation by G protein-coupled receptors may identify new signaling paradigms. A gastrin-releasing peptide (GRP)/GRP receptor-mediated autocrine pathway was previously described in squamous cell carcinoma of head and neck. In the present study, we demonstrate that TNF-alpha converting enzyme (TACE), a disintegrin and metalloproteinse-17, undergoes a Src-dependent phosphorylation that regulates release of the EGFR ligand amphiregulin upon GRP treatment. Further investigation reveals the phosphatidylinositol 3-kinase (PI3-K) as the intermediate of c-Src and TACE, contributing to their association and TACE phosphorylation. Phosphoinositide-dependent kinase 1 (PDK1), a downstream target of PI3-K, has been identified as the previously undescribed kinase to directly phosphorylate TACE upon GRP treatment. These findings suggest a signaling cascade of GRP-Src-PI3-K-PDK1-TACE-amphiregulin-EGFR with multiple points of interaction, translocation, and phosphorylation. Furthermore, knockdown of PDK1 augmented the antitumor effects of the EGFR inhibitor erlotinib, indicating PDK1 as a therapeutic target to improve the clinical response to EGFR inhibitors.

Citing Articles

ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection.

Engler M, Albers D, von Maltitz P, Gross R, Munch J, Cirstea I Life Sci Alliance. 2023; 6(9).

PMID: 37402592 PMC: 10320016. DOI: 10.26508/lsa.202201880.


NOTCH1 Signalling: A key pathway for the development of high-risk chronic lymphocytic leukaemia.

Edelmann J Front Oncol. 2022; 12:1019730.

PMID: 36313682 PMC: 9606825. DOI: 10.3389/fonc.2022.1019730.


Analysis of the epidermal growth factor receptor/phosphoinositide-dependent protein kinase-1 axis in tumor of the external auditory canal in response to epidermal growth factor stimulation.

Akiyama N, Yamamoto-Fukuda T, Yoshikawa M, Kojima H Laryngoscope Investig Otolaryngol. 2022; 7(3):730-739.

PMID: 35734041 PMC: 9195017. DOI: 10.1002/lio2.785.


ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Yang H, Khalil R Adv Pharmacol. 2022; 94:255-363.

PMID: 35659374 PMC: 9231755. DOI: 10.1016/bs.apha.2021.11.002.


Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma.

Kordbacheh F, Farah C Cancers (Basel). 2021; 13(14).

PMID: 34298667 PMC: 8307423. DOI: 10.3390/cancers13143453.


References
1.
Roelle S, Grosse R, Aigner A, Krell H, Czubayko F, Gudermann T . Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem. 2003; 278(47):47307-18. DOI: 10.1074/jbc.M304377200. View

2.
Zwick E, Daub H, Aoki N, Tinhofer I, Maly K, Ullrich A . Critical role of calcium- dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem. 1997; 272(40):24767-70. DOI: 10.1074/jbc.272.40.24767. View

3.
Biondi R, Nebreda A . Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem J. 2003; 372(Pt 1):1-13. PMC: 1223382. DOI: 10.1042/BJ20021641. View

4.
Lopez-Ilasaca M, Crespo P, Pellici P, Gutkind J, Wetzker R . Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science. 1997; 275(5298):394-7. DOI: 10.1126/science.275.5298.394. View

5.
Thomas S, Grandis J, Wentzel A, Gooding W, Lui V, Siegfried J . Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cells. Neoplasia. 2005; 7(4):426-31. PMC: 1501149. DOI: 10.1593/neo.04454. View